Intraoperative Manual Correction of Iliosacral Displacement of the Sacroiliac Joint in Total Hip Arthroplasty

Sponsor
I.M. Sechenov First Moscow State Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04673747
Collaborator
(none)
80
1
2
59
1.4

Study Details

Study Description

Brief Summary

Degenerative changes in the hip joint, which are indications for operative treatment, are observed in more than 30% over the age of 50. In most cases, the development of a degenerative process in the hip joint is accompanied by changes in the sacroiliac joint. To improve the quality of life, relieve pain, improve the clinical outcomes of rehabilitation after total hip arthroplasty (THA), an integrated approach to treatment is required.

The investigators have developed a technique for intraoperative manual correction of the ileosacral displacement of the sacroiliac joint during THA. This clinical study compares the use of this technique during THA and THA by standard method.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Total Hip Arthroplasty
  • Procedure: Manual correction of the sacroiliac joint
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Intraoperative Manual Correction of Iliosacral Displacement of the Sacroiliac Joint in Total Hip Arthroplasty
Actual Study Start Date :
Jun 1, 2017
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1 (Total Hip Arthroplasty with intraoperative manual correction)

Patients will undergo total hip arthroplasty with intraoperative manual correction of Iliosacral displacement of the sacroiliac joint

Procedure: Total Hip Arthroplasty
Total replacement of the head, femoral neck and acetabulum of the hip joint with specialized implants

Procedure: Manual correction of the sacroiliac joint
Manual correction of the iliosacral displacement of the sacroiliac joint in total hip arthroplasty is performed in the operating room after anesthesia just before total hip arthroplasty. It is carried out according to the methodology developed by us.

Active Comparator: Group 2 (Total hip Arthroplasty: standard method)

Patients will undergo total hip arthroplasty according to the standard method

Procedure: Total Hip Arthroplasty
Total replacement of the head, femoral neck and acetabulum of the hip joint with specialized implants

Outcome Measures

Primary Outcome Measures

  1. Pain assessment [before surgery]

    Visual Analogue Scale (VAS) - assessment or the severity of pain syndrome. The score is determined by measuring the distance (mm) on a 10 cm line between the no pain anchor point and the patient's mark, giving a value range from 0 to 100 (0 - min; 100- max)

  2. Pain assessment [3 months after surgery]

    Visual Analogue Scale (VAS) - assessment or the severity of pain syndrome. The score is determined by measuring the distance (mm) on a 10 cm line between the no pain anchor point and the patient's mark, giving a value range from 0 to 100 (0 - min; 100- max)

  3. Pain assessment [6 months after surgery]

    Visual Analogue Scale (VAS) - assessment or the severity of pain syndrome. The score is determined by measuring the distance (mm) on a 10 cm line between the no pain anchor point and the patient's mark, giving a value range from 0 to 100 (0 - min; 100- max)

  4. Pain assessment [12 months after surgery]

    Visual Analogue Scale (VAS) - assessment or the severity of pain syndrome. The score is determined by measuring the distance (mm) on a 10 cm line between the no pain anchor point and the patient's mark, giving a value range from 0 to 100 (0 - min; 100- max)

  5. Hip function assessment [before surgery]

    The Harris Hip Score (HSS). The HHS is a measure of disfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.

  6. Hip function assessment [3 months after surgery]

    The Harris Hip Score (HSS). The HHS is a measure of disfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.

  7. Hip function assessment [6 months after surgery]

    The Harris Hip Score (HSS). The HHS is a measure of disfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.

  8. Hip function assessment [12 months after surgery]

    The Harris Hip Score (HSS). The HHS is a measure of disfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Written informed consent of the patient to participate in the study

  • Patients with osteoarthritis of the hip joint.

  • The opportunity for observation during the entire study period (12 months)

  • Mental adequacy, ability, willingness to cooperate and follow the doctor's recommendations

Exclusion Criteria:
  • The refusal of a patient from surgery

  • The presence of contraindications to surgery

  • Severe forms of diabetes (glycosylated hemoglobin >9%)

  • Previously performed surgeries on the lumbar spine

  • Blood diseases (thrombopenia, thrombocytopenia, anemia with Hb< 90g\l)

  • The unwillingness of the patient to conscious cooperation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sechenov University Moscow Russian Federation 119991

Sponsors and Collaborators

  • I.M. Sechenov First Moscow State Medical University

Investigators

  • Study Chair: Alexey Lychagin, MD, Phd, IM Sechenov University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
I.M. Sechenov First Moscow State Medical University
ClinicalTrials.gov Identifier:
NCT04673747
Other Study ID Numbers:
  • 1381
First Posted:
Dec 17, 2020
Last Update Posted:
Jun 16, 2021
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by I.M. Sechenov First Moscow State Medical University

Study Results

No Results Posted as of Jun 16, 2021